Cargando…
Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment?
Bladder cancer (BC) is the tenth most common cancer, and its incidence is steadily rising worldwide, with the highest rates in developed countries. Neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy is the standard therapy for patients with muscle-invasive bladder cancer. Howeve...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255239/ https://www.ncbi.nlm.nih.gov/pubmed/35800376 http://dx.doi.org/10.20517/cdr.2022.02 |